Published in Ann Neurol on August 30, 2014
The 2D:4D ratio, a proxy for prenatal androgen levels, differs in men with and without MS. Neurology (2015) 1.40
Testicular hypofunction and multiple sclerosis: Cause or consequence? Ann Neurol (2014) 1.06
Testicular hypofunction and multiple sclerosis: Cause or consequence? Reply. Ann Neurol (2014) 0.75
Emerging Approaches for Validating and Managing Multiple Sclerosis Relapse. Front Neurol (2017) 0.75
Unexpected central role of the androgen receptor in the spontaneous regeneration of myelin. Proc Natl Acad Sci U S A (2016) 0.75
Multiple sclerosis in men: management considerations. J Neurol (2016) 0.75
Low testosterone and myasthenia gravis in males: a national record-linkage study. J Neurol (2016) 0.75
A randomized, placebo-controlled trial of natalizumab for relapsing multiple sclerosis. N Engl J Med (2006) 11.29
Placebo-controlled phase 3 study of oral BG-12 for relapsing multiple sclerosis. N Engl J Med (2012) 7.58
Natalizumab-associated progressive multifocal leukoencephalopathy in patients with multiple sclerosis: lessons from 28 cases. Lancet Neurol (2010) 5.03
A ChIP-seq defined genome-wide map of vitamin D receptor binding: associations with disease and evolution. Genome Res (2010) 4.77
No cerebrocervical venous congestion in patients with multiple sclerosis. Ann Neurol (2010) 4.31
Alemtuzumab versus interferon beta 1a as first-line treatment for patients with relapsing-remitting multiple sclerosis: a randomised controlled phase 3 trial. Lancet (2012) 4.25
Efficacy and safety of oral fumarate in patients with relapsing-remitting multiple sclerosis: a multicentre, randomised, double-blind, placebo-controlled phase IIb study. Lancet (2008) 3.68
Increase in emergency admissions to hospital for children aged under 15 in England, 1999-2010: national database analysis. Arch Dis Child (2013) 3.61
Career progression and destinations, comparing men and women in the NHS: postal questionnaire surveys. BMJ (2009) 3.26
Doctors' reasons for rejecting initial choices of specialties as long-term careers. Med Educ (2003) 3.11
Recruitment of UK-trained doctors into general practice: findings from national cohort studies. Br J Gen Pract (2002) 2.89
Daclizumab high-yield process in relapsing-remitting multiple sclerosis (SELECT): a randomised, double-blind, placebo-controlled trial. Lancet (2013) 2.89
Effect of natalizumab on clinical and radiological disease activity in multiple sclerosis: a retrospective analysis of the Natalizumab Safety and Efficacy in Relapsing-Remitting Multiple Sclerosis (AFFIRM) study. Lancet Neurol (2009) 2.82
Career choices of United Kingdom medical graduates of 1999 and 2000: questionnaire surveys. BMJ (2003) 2.77
Determinants of the decline in mortality from acute myocardial infarction in England between 2002 and 2010: linked national database study. BMJ (2012) 2.73
Encephalitis lethargica syndrome: 20 new cases and evidence of basal ganglia autoimmunity. Brain (2003) 2.63
Time trends and demography of mortality after fractured neck of femur in an English population, 1968-98: database study. BMJ (2003) 2.56
Recommended standard of cerebrospinal fluid analysis in the diagnosis of multiple sclerosis: a consensus statement. Arch Neurol (2005) 2.55
Evidence for acute neurotoxicity after chemotherapy. Ann Neurol (2010) 2.45
Career choices of United Kingdom medical graduates of 2002: questionnaire survey. Med Educ (2006) 2.36
The clinical significance of an intrathecal monoclonal immunoglobulin band: a follow-up study. Neurology (2003) 2.35
Subsequent primary malignancies in patients with nonmelanoma skin cancer in England: a national record-linkage study. Cancer Epidemiol Biomarkers Prev (2014) 2.26
Breast cancer mortality trends in England and the assessment of the effectiveness of mammography screening: population-based study. J R Soc Med (2013) 2.20
Cancer in patients with motor neuron disease, multiple sclerosis and Parkinson's disease: record linkage studies. J Neurol Neurosurg Psychiatry (2009) 2.14
Multiple sclerosis: risk factors, prodromes, and potential causal pathways. Lancet Neurol (2010) 2.08
Risk of venous thromboembolism in people admitted to hospital with selected immune-mediated diseases: record-linkage study. BMC Med (2011) 1.89
Health-related quality of life in multiple sclerosis: effects of natalizumab. Ann Neurol (2007) 1.88
Changes in safety on England's roads: analysis of hospital statistics. BMJ (2006) 1.80
UK senior doctors' career destinations, job satisfaction, and future intentions: questionnaire survey. BMJ (2002) 1.78
Reasons why some UK medical graduates who initially choose psychiatry do not pursue it as a long-term career. Psychol Med (2006) 1.72
The risk of developing multiple sclerosis in individuals seronegative for Epstein-Barr virus: a meta-analysis. Mult Scler (2012) 1.71
Direct suppression of CNS autoimmune inflammation via the cannabinoid receptor CB1 on neurons and CB2 on autoreactive T cells. Nat Med (2007) 1.69
Case fatality rates after admission to hospital with stroke: linked database study. BMJ (2003) 1.66
Environmental factors and their timing in adult-onset multiple sclerosis. Nat Rev Neurol (2010) 1.64
Cannabinoids inhibit neurodegeneration in models of multiple sclerosis. Brain (2003) 1.62
Meta-analysis of early nonmotor features and risk factors for Parkinson disease. Ann Neurol (2012) 1.61
Reasons for considering leaving UK medicine: questionnaire study of junior doctors' comments. BMJ (2004) 1.60
UK doctors' views on the implementation of the European Working Time Directive as applied to medical practice: a qualitative analysis. BMJ Open (2014) 1.57
Mortality trends for benign prostatic hyperplasia and prostate cancer in English populations 1979-2006. BJU Int (2011) 1.54
The therapeutic potential of cannabis. Lancet Neurol (2003) 1.49
The efficacy of natalizumab in patients with relapsing multiple sclerosis: subgroup analyses of AFFIRM and SENTINEL. J Neurol (2009) 1.46
Risk stratification for progressive multifocal leukoencephalopathy in patients treated with natalizumab. Mult Scler (2012) 1.46
Guthrie card methylomics identifies temporally stable epialleles that are present at birth in humans. Genome Res (2012) 1.45
Guidelines for uniform reporting of body fluid biomarker studies in neurologic disorders. Neurology (2014) 1.45
Month of birth, vitamin D and risk of immune-mediated disease: a case control study. BMC Med (2012) 1.44
Career choices of the United Kingdom medical graduates of 2005, 2008 and 2009: questionnaire surveys. Med Teach (2013) 1.42
Using routine data to define clinical case-mix and compare hospital outcomes in urology. BJU Int (2006) 1.41
Doctors who considered but did not pursue specific clinical specialties as careers: questionnaire surveys. J R Soc Med (2012) 1.40
Epilepsy and the subsequent risk of cerebral tumour: record linkage retrospective cohort study. J Neurol Neurosurg Psychiatry (2011) 1.40
Obsessive-compulsive disorder and catatonia can be caused by antibasal ganglia antibodies. Cogn Behav Neurol (2007) 1.39
HERVs: have we been here before? Mult Scler (2012) 1.39
Recommendations for clinical use of data on neutralising antibodies to interferon-beta therapy in multiple sclerosis. Lancet Neurol (2010) 1.37
Long term lymphocyte reconstitution after alemtuzumab treatment of multiple sclerosis. J Neurol Neurosurg Psychiatry (2011) 1.37
An updated meta-analysis of risk of multiple sclerosis following infectious mononucleosis. PLoS One (2010) 1.36
Stiff person syndrome. Pract Neurol (2011) 1.36
Epstein-Barr virus and multiple sclerosis. Curr Opin Neurol (2009) 1.36
The month of birth effect in multiple sclerosis: systematic review, meta-analysis and effect of latitude. J Neurol Neurosurg Psychiatry (2012) 1.34
Mortality in patients with and without colectomy admitted to hospital for ulcerative colitis and Crohn's disease: record linkage studies. BMJ (2007) 1.34
Increased neurofilament light chain blood levels in neurodegenerative neurological diseases. PLoS One (2013) 1.32
Autoimmune disease preceding amyotrophic lateral sclerosis: an epidemiologic study. Neurology (2013) 1.31
Retracted Consensus Guidelines for CSF and Blood Biobanking for CNS Biomarker Studies. Mult Scler Int (2011) 1.26
Reasons why doctors choose or reject careers in general practice: national surveys. Br J Gen Pract (2012) 1.25
Cerebrospinal fluid biomarkers in multiple sclerosis. Neurobiol Dis (2009) 1.22
Gender, ethnicity and graduate status, and junior doctors' self-reported preparedness for clinical practice: national questionnaire surveys. J R Soc Med (2013) 1.22
Risk of invasive pneumococcal disease in people admitted to hospital with selected immune-mediated diseases: record linkage cohort analyses. J Epidemiol Community Health (2012) 1.19
What went wrong? The flawed concept of cerebrospinal venous insufficiency. J Cereb Blood Flow Metab (2013) 1.19
The McDonald Criteria for Multiple Sclerosis: time for clarification. Mult Scler (2010) 1.19
Cerebrospinal fluid oligoclonal bands in multiple sclerosis and clinically isolated syndromes: a meta-analysis of prevalence, prognosis and effect of latitude. J Neurol Neurosurg Psychiatry (2013) 1.19
Prevalence of anti-basal ganglia antibodies in adult obsessive-compulsive disorder: cross-sectional study. Br J Psychiatry (2012) 1.19
Long-term survival and recurrence after acute myocardial infarction in England, 2004 to 2010. Circ Cardiovasc Qual Outcomes (2012) 1.17
Clinical efficacy of BG-12 (dimethyl fumarate) in patients with relapsing-remitting multiple sclerosis: subgroup analyses of the DEFINE study. J Neurol (2013) 1.17
Mortality rates and self reported health: database analysis by English local authority area. BMJ (2004) 1.16
Career plans and views of trainees in the Academic Clinical Fellowship Programme in England. Med Teach (2011) 1.16
Immunopathogenic mechanisms in tourette syndrome: A critical review. Mov Disord (2009) 1.16
Smoking and multiple sclerosis: an updated meta-analysis. PLoS One (2011) 1.16
Neuronal surface glycolytic enzymes are autoantigen targets in post-streptococcal autoimmune CNS disease. J Neuroimmunol (2005) 1.14
Views of UK-trained medical graduates of 1999-2009 about their first postgraduate year of training: national surveys. BMJ Open (2013) 1.11
Cardiovascular fitness as a risk factor for amyotrophic lateral sclerosis: indirect evidence from record linkage study. J Neurol Neurosurg Psychiatry (2011) 1.10
Epstein Barr virus is not a characteristic feature in the central nervous system in established multiple sclerosis. Brain (2009) 1.09
Vitamin D supplementation and antibodies against the Epstein-Barr virus in multiple sclerosis patients. Mult Scler (2013) 1.09
A comparative study of CSF neurofilament light and heavy chain protein in MS. Mult Scler (2013) 1.09
Career destinations and views in 1998 of the doctors who qualified in the United Kingdom in 1993. Med Educ (2002) 1.08
Increase of uric acid and purine compounds in biological fluids of multiple sclerosis patients. Clin Biochem (2009) 1.07
UK doctors' views on the implementation of the European Working Time Directive as applied to medical practice: a quantitative analysis. BMJ Open (2014) 1.07
Influence of maternal and perinatal factors on subsequent hospitalisation for asthma in children: evidence from the Oxford record linkage study. BMC Pulm Med (2010) 1.06
No evidence of disease activity: indirect comparisons of oral therapies for the treatment of relapsing-remitting multiple sclerosis. Adv Ther (2014) 1.05
Validating parameters of a luciferase reporter gene assay to measure neutralizing antibodies to IFNbeta in multiple sclerosis patients. J Immunol Methods (2008) 1.03
Effect of BG-12 on contrast-enhanced lesions in patients with relapsing--remitting multiple sclerosis: subgroup analyses from the phase 2b study. Mult Scler (2011) 1.03
The PANDAS subgroup of tic disorders and childhood-onset obsessive-compulsive disorder. J Psychosom Res (2009) 1.03
Revised McDonald criteria: the persisting importance of cerebrospinal fluid analysis. Ann Neurol (2011) 1.02
Association of infectious mononucleosis with multiple sclerosis. A population-based study. Neuroepidemiology (2009) 1.02
Multiple sclerosis: a practical overview for clinicians. Br Med Bull (2010) 1.01
Mortality in young people admitted to hospital for diabetes: database study. BMJ (2004) 1.00
PREDICT-PD: identifying risk of Parkinson's disease in the community: methods and baseline results. J Neurol Neurosurg Psychiatry (2013) 0.99
Natalizumab-associated progressive multifocal leucoencephalopathy: a practical approach to risk profiling and monitoring. Pract Neurol (2012) 0.98